Key Takeaways
- UnitedHealth Group is set to report fourth-quarter earnings before the market opens Thursday.
- All 17 analysts tracked by Visible Alpha have a “buy” or equivalent rating and the consensus price target suggests a close to 10% rise in the shares is expected.
- The results will be the company’s first since the CEO of its UnitedHealthcare unit was fatally shot on Dec. 4.
UnitedHealth Group (UNH) is set tꦐo report fourth-quarter earnings before the market opens Thursday, and analysts are widely ❀bullish ahead of the results.
All 17 analysts tracked by Visible Alpha have a “buy” or equivalent rating, and the consensus price target of nearly $642. That’s a more than 18% premium to UnitedHealth's Monday close around $541.
Wall Street expects the company to report fourth-quarter revenue of $101.68 billion, up 8% year-over-year, and earnings of $5.84 billion, or $𓃲6.30 per share, compared to $5.46 billion, or $5.83 per share, a year earlier.
The company last month shared its financial outlook for 2025, which included forecasts of revenue of $450 billion to $455 billion, and adjusted net income of $29.50 per share to $30 per share.
Thursday’s results will be the company’s first quarterly report since the CEO of its UnitedHealthcare unit, Brian Thompson, was 澳洲幸运5官方开奖结果体彩网:fatally shot on Dec. 4. The company’s♓ shares have fallen more than 10% in the weeks since.
UnitedHealth shares rose nearly 4% on Monday as broader markets 澳洲幸运5官方开奖结果体彩网:finished mixed.